RILPL2 Inhibitors
Chemical inhibitors of RILPL2 play a role in modulating its function by targeting various signaling pathways and molecular interactions that are essential for its activity. Go6976, for example, directly inhibits protein kinase C, which is necessary for RILPL2's phosphorylation and activation. By preventing these phosphorylation events, Go6976 can inhibit the function of RILPL2. Similarly, ML141 and ZCL278 function as Cdc42 inhibitors; Cdc42 is a small GTPase that interacts with RILPL2, and its inhibition disrupts RILPL2's role in the reorganization of the actin cytoskeleton. Y-27632 targets the Rho-associated kinase (ROCK), and by inhibiting ROCK, it can impair the RILPL2-mediated stress fiber formation, which is a crucial part of actin cytoskeletal dynamics. NSC23766 specifically blocks the interaction between Rac1 and its guanine nucleotide exchange factors (GEFs), thereby reducing Rac1 activity, which is also linked to RILPL2's function.
Further, SecinH3, by inhibiting cytohesins, can indirectly inhibit RILPL2 function, considering that cytohesins are involved in membrane trafficking, a process with which RILPL2 is implicated. LY294002, a PI3K inhibitor, affects upstream regulators of actin remodeling pathways, where RILPL2 is active. The inhibition of PI3K by LY294002, therefore, can lead to functional limitation of RILPL2. PF-562271 inhibits focal adhesion kinase (FAK), an integral component of integrin signaling and cytoskeletal reorganization, which are processes that involve RILPL2. IPA-3 and Wiskostatin, on the other hand, target proteins that are activated by Cdc42 and Rac1, such as PAK1 and N-WASP, respectively. As these kinases and effector proteins are part of pathways that RILPL2 interacts with, their inhibition by IPA-3 and Wiskostatin can lead to the functional disruption of RILPL2. Lastly, CK-666 and SMIFH2 inhibit the Arp2/3 complex and formin-mediated actin assembly, both of which are crucial for actin polymerization and cytoskeletal rearrangement where RILPL2 plays a role. By inhibiting these elements of the actin assembly machinery, CK-666 and SMIFH2 can impair the function of RILPL2 in actin dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Go6976 is a potent inhibitor of protein kinase C (PKC), which directly inhibits RILPL2 by preventing PKC-mediated phosphorylation events that are necessary for RILPL2's activation and function. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a potent inhibitor of Cdc42, a small GTPase interacting with RILPL2. Inhibition of Cdc42 by ML141 disrupts its interaction with RILPL2, which is crucial for RILPL2-mediated reorganization of the actin cytoskeleton. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 selectively inhibits ROCK, a downstream effector of Rho, leading to reduced stress fiber formation. As RILPL2 is implicated in Rho-mediated actin organization, inhibition of ROCK by Y-27632 impairs RILPL2's role in actin cytoskeletal dynamics. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 inhibits cytohesins, which are guanine nucleotide exchange factors (GEFs) for ADP-ribosylation factors (ARFs), affecting membrane trafficking. Inhibition of cytohesins can indirectly inhibit RILPL2 by disrupting membrane dynamics and trafficking processes that RILPL2 is implicated in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, an upstream regulator of many signaling pathways including those involving actin cytoskeleton remodeling where RILPL2 has a role. Inhibition of PI3K activity by LY294002 can lead to the functional inhibition of RILPL2. | ||||||
PF-562271 | 717907-75-0 | sc-478488 sc-478488A sc-478488B | 5 mg 10 mg 50 mg | $312.00 $474.00 $1124.00 | 3 | |
PF-562271 is a potent inhibitor of focal adhesion kinase (FAK), which plays a key role in integrin signaling and actin cytoskeletal reorganization, processes that RILPL2 is involved in. By inhibiting FAK, PF-562271 can lead to the functional inhibition of RILPL2. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
ZCL278 is a Cdc42 inhibitor that blocks the binding of Cdc42 to its effector proteins. As RILPL2 interacts with Cdc42, the inhibition by ZCL278 can lead to the functional inhibition of RILPL2 by preventing its participation in Cdc42-mediated signaling pathways. | ||||||
IPA 3 | 42521-82-4 | sc-204016 sc-204016A | 5 mg 50 mg | $94.00 $458.00 | 6 | |
IPA-3 selectively inhibits PAK1, a kinase that is activated by Cdc42 and Rac1. Since RILPL2 interacts with these small GTPases, inhibition of PAK1 by IPA-3 can lead to the functional inhibition of RILPL2 by disrupting downstream signaling. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin is a specific inhibitor of the N-WASP, which is an effector of Cdc42 involved in actin polymerization. RILPL2's function is tied to actin cytoskeletal dynamics; therefore, inhibition by Wiskostatin can disrupt processes crucial for RILPL2 function. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
CK-666 is an inhibitor of the Arp2/3 complex, which is involved in the initiation of actin polymerization. RILPL2 has a role in actin cytoskeleton organization, and by inhibiting the Arp2/3 complex, CK-666 can impair RILPL2's participation in actin-related activities. | ||||||